Enanta Pharmaceuticals Inc.
Organization details
- Legal name
- Enanta Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Headquarters city
- Watertown
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- September
- Ticker symbol
- ENTA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001177648
- EIN
- 04-3205099
Board of directors
-
Bruce L. A. Carter · DirectorSince 2023
-
Jay R. Luly · Director · President and CEOSince 2023
-
Kristine Peterson · DirectorSince 2023
-
Lesley Russell · DirectorSince 2023
-
Mark G. Foletta · DirectorSince 2023
-
Terry Vance · DirectorSince 2023
-
Yujiro S. Hata · DirectorSince 2023
Chief executives
Director election results
Annual meeting of March 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
81.4%
-
99.2%
Board connections
3 of this board's directors also sit on 6 other boards. 5 are in the same sector.
- via Mark G. Foletta
-
ArriVent BioPharma Inc. Same sectorvia Kristine Peterson
-
DexCom Inc. Same sectorvia Mark G. Foletta
-
IDEAYA Biosciences Inc. Same sectorvia Yujiro S. Hata
-
Immunocore Holdings plc Same sectorvia Kristine Peterson
-
Mineralys Therapeutics Inc. Same sectorvia Kristine Peterson
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $183,167
- 9 sales by 7 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 8, 2026 | Rottinghaus Scott T. Officer (Chief Medical Officer) | Shares withheld for tax | −1,467 | $13.34 | $19,570 |
| Feb 12, 2026 | Kowalsky Matthew Paul Officer (Chief Legal Officer) | Grant or award | +1,318 | — | — |
| Feb 12, 2026 | Luu Brendan Officer (Chief Business Officer) | Grant or award | +1,575 | — | — |
| Feb 12, 2026 | Kieffer Tara Lynn Officer (Chief Product Strategy Officer) | Grant or award | +1,575 | — | — |
| Feb 12, 2026 | Rottinghaus Scott T. Officer (Chief Medical Officer) | Grant or award | +1,650 | — | — |
| Feb 12, 2026 | Or Yat Sun Officer (Chief Scientific Officer) | Grant or award | +1,650 | — | — |
| Feb 12, 2026 | Jay R. Luly Director, Officer (President and CEO) | Grant or award | +4,800 | — | — |
| Feb 12, 2026 | Kowalsky Matthew Paul Officer (Chief Legal Officer) | Grant or award | +4,175 | — | — |
| Feb 12, 2026 | Luu Brendan Officer (Chief Business Officer) | Grant or award | +4,987 | — | — |
| Feb 12, 2026 | Kieffer Tara Lynn Officer (Chief Product Strategy Officer) | Grant or award | +4,987 | — | — |
| Feb 12, 2026 | Rottinghaus Scott T. Officer (Chief Medical Officer) | Grant or award | +5,225 | — | — |
| Feb 12, 2026 | Or Yat Sun Officer (Chief Scientific Officer) | Grant or award | +5,225 | — | — |
| Feb 12, 2026 | Jay R. Luly Director, Officer (President and CEO) | Grant or award | +15,200 | — | — |
| Feb 12, 2026 | Kowalsky Matthew Paul Officer (Chief Legal Officer) | Shares withheld for tax | −1,902 | $14.25 | $27,104 |
| Feb 12, 2026 | Luu Brendan Officer (Chief Business Officer) | Shares withheld for tax | −3,257 | $14.25 | $46,412 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Enanta Pharmaceuticals Inc.
Who is the CEO of Enanta Pharmaceuticals Inc.?
Jay R. Luly is Enanta Pharmaceuticals Inc.'s President and CEO.
How many directors are on Enanta Pharmaceuticals Inc.'s board?
Enanta Pharmaceuticals Inc.'s board has 7 directors: Bruce L. A. Carter, Jay R. Luly, Kristine Peterson, Lesley Russell, Mark G. Foletta, Terry Vance and Yujiro S. Hata.
Are Enanta Pharmaceuticals Inc. insiders buying or selling shares?
Over the last 12 months, Enanta Pharmaceuticals Inc. insiders made no open-market purchases and sold $183,167 of shares in 9 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="enanta-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.